Stay updated on Antimicrobial Immunomodulation in PSC Clinical Trial
Sign up to get notified when there's something new on the Antimicrobial Immunomodulation in PSC Clinical Trial page.

Latest updates to the Antimicrobial Immunomodulation in PSC Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record for oral vancomycin treatment of primary sclerosing cholangitis is displayed, with study details, participant criteria, treatment procedures, outcome measures, and related publications.SummaryDifference43%

- Check11 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check25 days agoChange DetectedA sitewide banner announces an NIH transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision label also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden error page with the site header and footer. It indicates restricted access to the study record and shows the standard navigation elements.SummaryDifference100%

Stay in the know with updates to Antimicrobial Immunomodulation in PSC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antimicrobial Immunomodulation in PSC Clinical Trial page.